Targeting miRNA-551b, a "Stemness"-like microRNA, to Eradicate AML (Stem) Cells

干细胞 造血 髓系白血病 生物 小RNA 癌症研究 白血病 下调和上调 祖细胞 化疗 造血干细胞 骨髓 免疫学 基因 遗传学
作者
Tània Martiáñez,Noortje van Gils,David C. de Leeuw,Eline Vermue,Arjo Rutten,Fedor Denkers,Han Verhagen,Jeroen J. W. M. Janssen,Gert J. Ossenkoppele,Connie R. Jiménez,Linda Smit
出处
期刊:Blood [Elsevier BV]
卷期号:132 (Supplement 1): 1494-1494
标识
DOI:10.1182/blood-2018-99-116024
摘要

Abstract Despite high complete remission (CR) rates achieved after chemotherapy, only 30-40% of patients with Acute Myeloid Leukemia (AML) survive five years after diagnosis. The main cause of this treatment failure is insufficient eradication of a subpopulation of chemotherapy-resistant leukemia cells with stem cell properties, named "leukemic stem cells" (LSCs). LSCs use a variety of mechanisms to resist chemotherapy and targeting them is one of the major challenges in AML treatment. Since miRNAs can target multiple genes/pathways simultaneously, their modulation (downregulation or upregulation) may have great potential for the successful elimination of therapy-resistant leukemic (stem) cells (Martiañez Canales et al. Cancers 2017). Here, we show that miRNA-551b, previously identified by us as a stem cell-like miRNA, can be a potential novel target to specifically eradicate AML stem-like cells. Aiming at identification of miRNA-based therapy to specifically eradicate LSCs, while sparing normal Hematopoietic Stem Cells (HSCs), we determined expression of miRNAs in normal HSCs, Leukemic Stem Cells (LSCs) and leukemic progenitors (LP) all derived from the same AML patient's bone marrow. Using this approach, we identified miRNA-551b as being highly expressed in normal HSCs residing both in healthy and AML bone marrows. In AML, high expression of miR551b demonstrated to be associated with an adverse prognosis. Moreover, miRNA-551b was highly expressed in immature AML cases and its expression in a cohort of patients coincided with the expression of stem cell genes (De Leeuw et al. Leukemia 2016). To further elucidate the link between miRNA-551b and AML "stemness" and to test whether downregulation of miRNA-551b affects the survival of AML (stem/progenitor) cells, proliferation and the balance between differentiation and "stemness", we reduced miRNA-551b expression, either by lentiviral transduction of antagomirs or by adding locked nucleotide acid (LNA)-oligonucleotides to AML cell lines and primary AML cells. Downregulation of miRNA-551b in the stem cell-like AML cell line KG1a led to inhibition of cell growth in vitro, which was due to inhibition of proliferation rather than induction of apoptosis. KG1a tumor growth in an in vivo mouse model was also reduced when miRNA-551b was downregulated. In primary AML, miRNA-551b knockdown resulted in a significant decrease in the survival of leukemic progenitors and LSCs, while hematopoietic stem cells (HSCs) and normal progenitors from healthy bone marrows were not affected. These results suggest that a therapeutic approach inhibiting miRNA-551b expression might specifically eradicate leukemic progenitors and LSCs from primary AML, while sparing HSCs. We are currently studying miRNA-551b targets which can be responsible for this specific LSCs elimination. In conclusion, our results suggest that inhibition of miRNA-551b could be a promising approach to eliminate stem cell-like AML cells, thereby decreasing relapse rates and improving AML treatment outcome. Disclosures Ossenkoppele: Pfizer: Consultancy, Honoraria; BMS: Consultancy, Honoraria; Genentech: Consultancy, Honoraria; Jazz: Consultancy, Honoraria; Novartis: Consultancy, Honoraria, Research Funding; Karyopharm: Consultancy, Research Funding; Roche: Consultancy, Honoraria; Celgene: Honoraria, Research Funding; Johnson & Johnson: Consultancy, Honoraria, Research Funding; Genmab: Research Funding.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
群山完成签到 ,获得积分10
1秒前
mongmong完成签到 ,获得积分10
2秒前
3秒前
春夏完成签到 ,获得积分10
3秒前
卢彦冬完成签到,获得积分10
5秒前
6秒前
冷静以山完成签到 ,获得积分10
10秒前
飞儿完成签到 ,获得积分10
12秒前
369ninja发布了新的文献求助10
12秒前
兴奋的惮完成签到,获得积分10
13秒前
进击的牛马完成签到,获得积分10
13秒前
游01完成签到 ,获得积分10
15秒前
打打的应助被活泼雪莲采纳,获得10
17秒前
zhuangbaobao完成签到,获得积分10
17秒前
18秒前
个性怡完成签到 ,获得积分10
18秒前
深情的乐萱完成签到,获得积分10
18秒前
雪山大地发布了新的文献求助10
20秒前
失眠的寄云完成签到,获得积分10
23秒前
23秒前
O_0完成签到 ,获得积分10
23秒前
WQ完成签到,获得积分10
23秒前
莹莹大王发布了新的文献求助10
28秒前
落月无痕完成签到,获得积分10
30秒前
win050532完成签到 ,获得积分10
31秒前
吃饭打肯德基完成签到 ,获得积分10
33秒前
马伯乐完成签到 ,获得积分10
35秒前
Qinzhiyuan1990完成签到 ,获得积分10
35秒前
Lytoo完成签到 ,获得积分10
36秒前
37秒前
Enyu完成签到 ,获得积分10
39秒前
紧张的绮玉完成签到 ,获得积分10
42秒前
雪山大地发布了新的文献求助10
42秒前
43秒前
喂喂喂完成签到 ,获得积分10
46秒前
Bismarck完成签到 ,获得积分10
46秒前
wanci的应助被酷酷的怀莲采纳,获得50
48秒前
活泼雪莲发布了新的文献求助10
49秒前
52秒前
爱而不得完成签到 ,获得积分10
52秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Hidden Empire of Finance: How Wall Street Profits from Our Cities and Fuels Global Inequality 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8166550
求助须知:如何正确求助?哪些是违规求助? 9559535
关于积分的说明 21750720
捐赠科研通 7757357
什么是DOI,文献DOI怎么找? 3429141
关于科研通互助平台的介绍 2553523
邀请新用户注册赠送积分活动 2473904